No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Zyter Virtual Rounding: HIPAA Compliant, Cloud-based Telehealth Solution That Enables Physicians to Conduct Virtual Hospital Rounds: Increases Safety During COVID-19 Pandemic

Editor: What To Know

  • In the latter scenario, a clinician at the hospital will place a tablet with Zyter Virtual Rounding on a stand at the patient's bedside for the patient to use during the virtual visit.
  • Physicians have the flexibility to conduct virtual rounding in two ways – physically in the patient's room while using Zyter Virtual Rounding on a tablet while the care team attends virtually, or remotely from the physician's office or any other location.
  • More than a secure video chat platform, Zyter Virtual Rounding integrates with the hospital's electronic health record (EHR) system to give physicians and care teams real-time access to the patient's EHR within the Zyter solution's context-aware video chat as they conduct the virtual visit.

Zyter Virtual Rounding solution features multi-party video chat, that makes it possible for nurses, residents, medical students, and even the patient’s family members to remotely and safely participate in virtual visits in COVID-19 wards and all other hospital units.

More than a secure video chat platform, Zyter Virtual Rounding integrates with the hospital’s electronic health record (EHR) system to give physicians and care teams real-time access to the patient’s EHR within the Zyter solution’s context-aware video chat as they conduct the virtual visit. As a result, physicians and nurses have the patient’s medical history, test results, medications, and more, instantly at their fingertips to help them provide prompt, more informed care during rounds. Hospital residents and medical students accompanying physicians on virtual rounds also benefit from the learning experience of having a comprehensive view of each patient’s case.

Physicians have the flexibility to conduct virtual rounding in two ways – physically in the patient’s room while using Zyter Virtual Rounding on a tablet while the care team attends virtually, or remotely from the physician’s office or any other location. In the latter scenario, a clinician at the hospital will place a tablet with Zyter Virtual Rounding on a stand at the patient’s bedside for the patient to use during the virtual visit. The physician initiates a virtual visit on Zyter Virtual Rounding by clicking on a patient’s hospital room number. The patient, the care team, and the patient’s family members all receive notification of the virtual visit via email or SMS messaging so they can connect and participate.

Using Zyter Virtual Rounding, hospitals can improve clinical workflow and patient care while enhancing the safety of physicians and patients during rounds, especially during the current COVID-19 pandemic. Another benefit of Zyter Virtual Rounding is the potential cost savings on personal protective equipment (PPE) by reducing the number of care team members who are physically present in the patient’ room. For example, only the physician in the room requires PPE, while the six or more residents or medical students attending remotely through the application do not. 

“Zyter Virtual Rounding is a game changer as it enables physicians and others to not only see the patient, but also see every detail of that patient’s medical record during a video chat call,” said Sanjay Govil, founder and CEO of Zyter, Inc. “By bringing in more data, the quality of care during virtual rounds can increase because physicians have a complete, holistic view of their patients and conditions.”

Zyter Virtual Rounding easily scales up to any number of participants and can be securely accessed through a browser on any iOS or Android digital tablet or mobile device with a cellular or Internet connection. Zyter Virtual Rounding can also be integrated with other telehealth solutions such as in-home visits, patient device monitoring, and remote patient monitoring.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy